formally known as gpha

Same medicine. Same results.
Lower cost.

GPhA Names Allen Goldberg Vice President, Communications

Contact: Steve Arnoff 202.249.7113 

WASHINGTON, DC (April 6, 2016) — The Generic Pharmaceutical Association (GPhA) today announced the hiring of Allen Goldberg, Vice President, Communications.

Goldberg is a communications professional with 30 years of experience working with health technology and research, multinational corporations and trade associations.

“We are thrilled to welcome Allen Goldberg to the GPhA team. His experience with brand building, patient advocacy and marketing communications will enhance the generic industry’s share of voice and help drive the value proposition of the generic and biosimilar sectors and their critical role in advancing patient health,” said Chip Davis, President and CEO, GPhA.

Prior to joining GPhA, Allen served as the Chief Marketing Officer of College Summit, a national nonprofit helping students from low-income communities get to and through college. Previously, Allen was Vice President of Communications for Neustar, Inc. (NYSE: NSR) a data and analytic solutions company and Chief Marketing Officer of FKF Applied Research, a business intelligence firm providing fMRI brain scan-based research. He began his career in public affairs working for three leading trade associations, the Grocery Manufacturers Association, the Food Marketing Institute and the National Association of Broadcasters.

Allen is co-founder and active board member of Hope for Henry Foundation, a nonprofit created to honor his son’s courageous fight with a rare disease. The organization is perhaps the only research and development lab in America focused on reinventing the pediatric patient experience to improve outcomes for kids fighting cancer and other serious illnesses.

About GPhA
GPhA represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk pharmaceutical chemicals, and suppliers of other goods and services to the generic industry. Generic pharmaceuticals fill 88 percent of the prescriptions dispensed in the U.S. but consume just 28 percent of the total drug spending. Additional information is available at Follow us on twitter: @gpha.